The Quidel QuickVue Influenza+SARS Test is a reliable point-of-care solution for rapid detection of Influenza types A and B along with SARS-CoV-2 antigens. Tailored for healthcare professionals, it aids in the timely diagnosis and management of infections, featuring a swift processing time of approximately 15 minutes. This dual-function test is essential for efficient epidemic control and patient care.

The kit is user-friendly, consisting of 25 tests per kit and 10 swabs, ensuring that healthcare facilities are well-equipped for immediate testing needs. Crafted to meet rigorous medical standards, the QuickVue Influenza+SARS Test ensures accurate detection right at the point of care, thereby facilitating better clinical outcomes. This rapid testing solution can significantly ease the workload on laboratories by providing prompt results, aiding in faster treatment and isolation protocols.

Key Features:

• Provides results quickly to facilitate faster decision-making in clinical settings.
• Includes comprehensive materials needed for conducting the tests, from swabs to controls.

Uses:

• The Quidel QuickVue Influenza+SARS Test Control Kit is used for the rapid detection of influenza types A and B and SARS-CoV-2 (COVID-19) antigens. It's particularly suitable for use in healthcare settings where time-efficient and accurate results are needed.

FAQs:

1. How quickly can results be obtained?
The QuickVue Influenza+SARS Test provides results in approximately 15 minutes, helping healthcare professionals make timely decisions.

2. Is the test suitable for all populations?
While the test is largely reliable, it is best used following a healthcare professional's guidance, particularly for asymptomatic or at-risk individuals.